PROFIBRIX

USPTO USPTO 2009 IR CANCELLED; US REGISTRATION CANCELLED

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die US-Marke PROFIBRIX wurde als Wortmarke am 17.09.2009 beim Amerikanischen Patent- und Markenamt angemeldet.
Sie wurde am 13.12.2011 im Markenregister eingetragen. Der aktuelle Status der Marke ist "IR CANCELLED; US REGISTRATION CANCELLED".

Markendetails

Markenform Wortmarke
Aktenzeichen 79075468
Registernummer 4069082
Anmeldedatum 17. September 2009
Veröffentlichungsdatum 27. September 2011
Eintragungsdatum 13. Dezember 2011

Markeninhaber

Zernikedreef 9
NL-2333 CK Leiden
NL

Waren und Dienstleistungen

5 Pharmaceutical preparations and substances for the treatment of bleeding and for tissue sealing; pharmaceutical preparations and substances for use as tissue sealants; haemostatic pharmaceutical compositions; pharmaceutical powder compositions for use as tissue sealants and/or as haemostatic compositions; pharmaceutical compositions for topical application to wounds; pharmaceutical compositions for topical application during surgical procedures for the treatment of bleeding and for tissue sealing; wound dressings; surgical dressings; bandages for dressing wounds; medicated wound dressings impregnated with tissue sealants and/or haemostatic compositions; medicated bandages impregnated with tissue sealants and/or haemostatic compositions; wound dressings, surgical dressings and bandages for dressing wounds, all incorporating tissue sealants and/or haemostatic compositions; pharmaceutical preparations and substances for use in delivery of drugs, genes, other therapeutic products or diagnostic agents, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical preparations for the treatment of internal bleeding; blood platelet substitutes; pharmaceutical compositions for coating blood vessels for the prevention and treatment of cardiovascular diseases and disorders; pharmaceutical compositions for intravascular administration for the prevention and treatment of cardiovascular diseases and disorders; pharmaceutical dry powder compositions comprising fibrin polymer for coating the internal surface of blood vessels for the prevention and treatment of cardiovascular diseases and disorders
10 Surgical, medical, dental and veterinary apparatus and instruments for administration of pharmaceutical compositions, namely, drug delivery systems; drug delivery systems, sold empty, for the delivery of pharmaceutical compositions for the treatment of bleeding and/or tissue sealing; drug delivery systems, sold empty, for the topical delivery of powdered pharmaceutical tissue sealants and/or haemostatic compositions; drug delivery systems, sold empty, for the delivery of tissue sealants to an internal or external surface of a patient; drug delivery systems, sold empty, for the delivery of haemostatic compositions by spraying; drug delivery systems, sold empty, for the delivery of pharmaceutical tissue sealants and/or haemostatic compositions during surgical procedures; surgical, medical, dental and veterinary apparatus and instruments for the prevention and treatment of cardiovascular diseases and disorders; drug delivery systems, sold empty, for intravascular delivery of pharmaceutical compositions for the prevention and/or treatment of cardiovascular diseases and disorders
42 Pharmaceutical drug development services; design services of new drug delivery systems; development of pharmaceutical formulations; scientific research and industrial research services in the field of pharmaceuticals and drug delivery systems
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

ID: 1379075468